MedTrace Logo

Clinical Evaluation of Topical Coenzyme Q10 in Management of Oral Aphthous Ulcer

NCT03213769 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2017-07-11

No results posted yet for this study

Summary

Recurrent oral aphthous ulcer is the most common oral lesion in occurrence and one of cause is oxidative stress so investigators need to use antioxidant drugs like topical coenzyme Q10 gel to treat the lesion and more safe for the participants.

Conditions

  • Oral Aphthous Ulcer

Interventions

DRUG

topical coenzyme Q10 gel

Q10 gel will give 2 times /day after breakfast and evening meal for 7 days.

DRUG

Carpabol gel

placebo carbapol gel will give 2 times /day after breakfast and evening meal for 7 days.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • fatheya zahran, professor · faculty of dentistry -CairoU

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-31
Primary Completion
2018-07-31
Completion
2018-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03213769 on ClinicalTrials.gov